Division of Clinical Innovation

Target entity: Division of Clinical Innovation
Context triple: [National Center for Advancing Translational Sciences, hasPart, Division of Clinical Innovation]

• A. Division of Pre-Clinical Innovation
  The Division of Pre-Clinical Innovation is a research branch of the National Center for Advancing Translational Sciences focused on developing and applying innovative preclinical methods to accelerate the translation of scientific discoveries into new therapies.
• B. Office of Quality and Patient Safety
  The Office of Quality and Patient Safety is a division of the New York State Department of Health responsible for overseeing and promoting healthcare quality improvement and patient safety across the state’s health care system.
• C. Center for Medicare and Medicaid Innovation
  The Center for Medicare and Medicaid Innovation is a federal agency within CMS that tests and implements new payment and service delivery models to improve quality and reduce costs in Medicare, Medicaid, and CHIP.
• D. Division of Extramural Research
  The Division of Extramural Research is a branch of the National Human Genome Research Institute that oversees and funds genome-related research conducted outside the institute.
• E. Office of Research and Development
  The Office of Research and Development is a specialized unit focused on planning, funding, and overseeing scientific and technological research initiatives within its parent organization.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target entity: Division of Clinical Innovation
Target entity description: The Division of Clinical Innovation is a branch of the National Center for Advancing Translational Sciences that focuses on improving and accelerating the translation of scientific discoveries into clinical applications and patient care.

• A. Division of Pre-Clinical Innovation
  The Division of Pre-Clinical Innovation is a research branch of the National Center for Advancing Translational Sciences focused on developing and applying innovative preclinical methods to accelerate the translation of scientific discoveries into new therapies.
• B. Office of Quality and Patient Safety
  The Office of Quality and Patient Safety is a division of the New York State Department of Health responsible for overseeing and promoting healthcare quality improvement and patient safety across the state’s health care system.
• C. Center for Medicare and Medicaid Innovation
  The Center for Medicare and Medicaid Innovation is a federal agency within CMS that tests and implements new payment and service delivery models to improve quality and reduce costs in Medicare, Medicaid, and CHIP.
• D. Division of Extramural Research
  The Division of Extramural Research is a branch of the National Human Genome Research Institute that oversees and funds genome-related research conducted outside the institute.
• E. Office of Research and Development
  The Office of Research and Development is a specialized unit focused on planning, funding, and overseeing scientific and technological research initiatives within its parent organization.
• F. None of above. chosen